Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
33,978,355
-
Share change
-
+8,872,148
-
Total reported value
-
$84,901,007
-
Put/Call ratio
-
37%
-
Price per share
-
$2.50
-
Number of holders
-
86
-
Value change
-
+$20,428,763
-
Number of buys
-
59
-
Number of sells
-
26
Institutional Holders of GALENA BIOPHARMA INC - COM (GALE) as of Q1 2014
As of 31 Mar 2014,
GALENA BIOPHARMA INC - COM (GALE) was held by
86 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,978,355 shares.
The largest 10 holders included
State Street Corp, Consonance Capital Management LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, VANGUARD GROUP INC, NORTHERN TRUST CORP, TIAA CREF INVESTMENT MANAGEMENT LLC, SABBY MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This page lists
86
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.